AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study Post author:Sam Post published:December 3, 2017 Post category:BioPharma Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries. Source: BioSpace You Might Also Like U.K. Could Seek Restitution from Pfizer if Legal Appeal Fails February 25, 2018 Bay Area's Ardelyx Nabs $160M Deal With Kyowa Hakko Kirin November 27, 2017 This Cancer Drug Could Bring in $3.8B for AstraZeneca January 18, 2018
